Created at Source Raw Value Validated value
June 25, 2024, noon usa

1. known or high suspicion of pre-existing heart failure, unstable angina 2. presence of severe shock with hemodynamic instability despite escalating vasopressors 3. severe, underlying lung disease (copd, pulmonary fibrosis, lung cancer. etc.) 4. concurrent treatments are delivered directly into the lung (ie anesthetics etc) 5. diagnosis of pulmonary hemorrhage

1. known or high suspicion of pre-existing heart failure, unstable angina 2. presence of severe shock with hemodynamic instability despite escalating vasopressors 3. severe, underlying lung disease (copd, pulmonary fibrosis, lung cancer. etc.) 4. concurrent treatments are delivered directly into the lung (ie anesthetics etc) 5. diagnosis of pulmonary hemorrhage

Nov. 16, 2021, 6:30 p.m. usa

known or high suspicion of pre-existing heart failure, unstable angina presence of severe shock with hemodynamic instability despite escalating vasopressors severe, underlying lung disease (copd, pulmonary fibrosis, lung cancer. etc.) concurrent treatments are delivered directly into the lung (ie anesthetics etc) diagnosis of pulmonary hemorrhage

known or high suspicion of pre-existing heart failure, unstable angina presence of severe shock with hemodynamic instability despite escalating vasopressors severe, underlying lung disease (copd, pulmonary fibrosis, lung cancer. etc.) concurrent treatments are delivered directly into the lung (ie anesthetics etc) diagnosis of pulmonary hemorrhage

Oct. 26, 2020, 11:31 p.m. usa

1. known or high suspicion of pre-existing heart failure, unstable angina 2. presence of severe shock with hemodynamic instability despite escalating vasopressors 3. severe, underlying lung disease (copd, pulmonary fibrosis, lung cancer. etc.) 4. concurrent treatments are delivered directly into the lung (ie anesthetics etc) 5. diagnosis of pulmonary hemorrhage

1. known or high suspicion of pre-existing heart failure, unstable angina 2. presence of severe shock with hemodynamic instability despite escalating vasopressors 3. severe, underlying lung disease (copd, pulmonary fibrosis, lung cancer. etc.) 4. concurrent treatments are delivered directly into the lung (ie anesthetics etc) 5. diagnosis of pulmonary hemorrhage